Lindbrook Capital’s Caesarstone CSTE Stock Holding History

Lindbrook Capital’s Portfolio CSTE Stock Details CSTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-45	Closed	–	–	2865
2022 Q3	$0	Buy	+45	New	+$433	﹤0.01%	2662

Other funds holding CSTE

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lindbrook Capital's CSTE Position: Q4 2022 in Review

Lindbrook Capital sold out of Caesarstone (CSTE) in Q4 2022, closing a stake of 45 shares.

Lindbrook Capital first reported a position in CSTE in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 89 funds tracked by Wall St. Rank hold CSTE as of Q4 2022.

Lindbrook Capital reported no remaining Caesarstone position as of Q4 2022 after selling out during the quarter.
Lindbrook Capital sold 45 Caesarstone shares in Q4 2022.
Lindbrook Capital first reported a position in Caesarstone in Q3 2022 and held it in 1 quarter.
Lindbrook Capital's Caesarstone position peaked at $0 in Q3 2022.
89 funds tracked by Wall St. Rank held Caesarstone as of Q4 2022.

Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.